269 related articles for article (PubMed ID: 11882573)
1. alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives.
Glorioso N; Filigheddu F; Cusi D; Troffa C; Conti M; Natalizio M; Argiolas G; Barlassina C; Bianchi G
Hypertension; 2002 Feb; 39(2 Pt 2):357-62. PubMed ID: 11882573
[TBL] [Abstract][Full Text] [Related]
2. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
Glorioso N; Manunta P; Filigheddu F; Troffa C; Stella P; Barlassina C; Lombardi C; Soro A; Dettori F; Parpaglia PP; Alibrandi MT; Cusi D; Bianchi G
Hypertension; 1999 Oct; 34(4 Pt 1):649-54. PubMed ID: 10523341
[TBL] [Abstract][Full Text] [Related]
3. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients.
Manunta P; Cusi D; Barlassina C; Righetti M; Lanzani C; D'Amico M; Buzzi L; Citterio L; Stella P; Rivera R; Bianchi G
Kidney Int; 1998 Jun; 53(6):1471-8. PubMed ID: 9607177
[TBL] [Abstract][Full Text] [Related]
4. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism.
Grant FD; Romero JR; Jeunemaitre X; Hunt SC; Hopkins PN; Hollenberg NH; Williams GH
Hypertension; 2002 Feb; 39(2):191-6. PubMed ID: 11847182
[TBL] [Abstract][Full Text] [Related]
5. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin.
Stenström K; Takemori H; Bianchi G; Katz AI; Bertorello AM
J Hypertens; 2009 Dec; 27(12):2452-7. PubMed ID: 19657284
[TBL] [Abstract][Full Text] [Related]
6. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.
Sciarrone MT; Stella P; Barlassina C; Manunta P; Lanzani C; Bianchi G; Cusi D
Hypertension; 2003 Mar; 41(3):398-403. PubMed ID: 12623934
[TBL] [Abstract][Full Text] [Related]
7. Human alpha-adducin gene, blood pressure, and sodium metabolism.
Kamitani A; Wong ZY; Fraser R; Davies DL; Connor JM; Foy CJ; Watt GC; Harrap SB
Hypertension; 1998 Jul; 32(1):138-43. PubMed ID: 9674650
[TBL] [Abstract][Full Text] [Related]
8. Localization and quantification of the cytoskeleton-associated protein adducin in the kidneys of normal and Milan hypertensive rats.
Ness W; Kaiser HW; Drenckhahn D
Histochem Cell Biol; 1998 Feb; 109(2):175-80. PubMed ID: 9504778
[TBL] [Abstract][Full Text] [Related]
9. alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption.
Torielli L; Tivodar S; Montella RC; Iacone R; Padoani G; Tarsini P; Russo O; Sarnataro D; Strazzullo P; Ferrari P; Bianchi G; Zurzolo C
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F478-87. PubMed ID: 18524856
[TBL] [Abstract][Full Text] [Related]
10. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension.
Ferrandi M; Salardi S; Tripodi G; Barassi P; Rivera R; Manunta P; Goldshleger R; Ferrari P; Bianchi G; Karlish SJ
Am J Physiol; 1999 Oct; 277(4):H1338-49. PubMed ID: 10516168
[TBL] [Abstract][Full Text] [Related]
11. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sodium-lithium countertransport in non-modulating offspring and essential hypertensive individuals: response to enalapril.
Sánchez RA; Giménez MI; Migliorini M; Giannone C; Ramírez AJ; Weder AB
Hypertension; 1997 Jul; 30(1 Pt 1):99-105. PubMed ID: 9231828
[TBL] [Abstract][Full Text] [Related]
13. Adducin in essential hypertension.
Manunta P; Barlassina C; Bianchi G
FEBS Lett; 1998 Jun; 430(1-2):41-4. PubMed ID: 9678591
[TBL] [Abstract][Full Text] [Related]
14. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
15. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'.
Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G
Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814
[TBL] [Abstract][Full Text] [Related]
16. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium.
Efendiev R; Krmar RT; Ogimoto G; Zwiller J; Tripodi G; Katz AI; Bianchi G; Pedemonte CH; Bertorello AM
Circ Res; 2004 Nov; 95(11):1100-8. PubMed ID: 15528469
[TBL] [Abstract][Full Text] [Related]
17. Genetic aspects of ion transport systems in hypertension.
Bianchi G; Ferrari P; Cusi D; Tripodi G; Barber B
J Hypertens Suppl; 1990 Dec; 8(7):S213-8. PubMed ID: 1710265
[TBL] [Abstract][Full Text] [Related]
18. Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
Manunta P; Maillard M; Tantardini C; Simonini M; Lanzani C; Citterio L; Stella P; Casamassima N; Burnier M; Hamlyn JM; Bianchi G
J Hypertens; 2008 May; 26(5):914-20. PubMed ID: 18398333
[TBL] [Abstract][Full Text] [Related]
19. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
Mead PA; Harvey JN; Rutherford PA; Leitch H; Thomas TH
Clin Sci (Lond); 2005 Mar; 108(3):231-6. PubMed ID: 15554870
[TBL] [Abstract][Full Text] [Related]
20. PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats.
Ferrandi M; Barassi P; Minotti E; Duzzi L; Molinari I; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 2002 Dec; 40(6):881-9. PubMed ID: 12451321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
